160 related articles for article (PubMed ID: 37884055)
1. Fracture Risk and Association With TDF Use Among People With HIV in Large Integrated Health Systems.
Hechter RC; Zhou H; Leyden WA; Yuan Q; Pak KJ; Lam JO; Alexeeff S; Lea A; Hu H; Marcus JL; Rivera AS; Adams AL; Horberg MA; Towner WJ; Lo JC; Silverberg MJ
J Acquir Immune Defic Syndr; 2023 Dec; 94(4):341-348. PubMed ID: 37884055
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis-Related Fractures in HIV-Infected Patients Receiving Long-Term Tenofovir Disoproxil Fumarate: An Observational Cohort Study.
Komatsu A; Ikeda A; Kikuchi A; Minami C; Tan M; Matsushita S
Drug Saf; 2018 Sep; 41(9):843-848. PubMed ID: 29623648
[TBL] [Abstract][Full Text] [Related]
3. Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens.
Nkhoma ET; Rosenblatt L; Myers J; Villasis-Keever A; Coumbis J
PLoS One; 2016; 11(12):e0166982. PubMed ID: 27941989
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054
[TBL] [Abstract][Full Text] [Related]
5. Association of tenofovir disoproxil fumarate exposure with chronic kidney disease and osteoporotic fracture in US veterans with HIV.
Sutton SS; Magagnoli J; Hardin JW; Hsu LI; Beaubrun A; Majethia S; Cummings TH
Curr Med Res Opin; 2020 Oct; 36(10):1635-1642. PubMed ID: 32856940
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN;
JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594
[TBL] [Abstract][Full Text] [Related]
7. Brief Report: Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals.
LaFleur J; Bress AP; Esker S; Knippenberg K; Crook J; Nyman H; Bedimo R; Tebas P; Rosenblatt L
J Acquir Immune Defic Syndr; 2018 Mar; 77(3):325-330. PubMed ID: 29210830
[TBL] [Abstract][Full Text] [Related]
8. Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score.
Hsu R; Brunet L; Fusco J; Beyer A; Prajapati G; Wyatt C; Wohlfeiler M; Fusco G
HIV Med; 2021 May; 22(5):325-333. PubMed ID: 33247876
[TBL] [Abstract][Full Text] [Related]
9. Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort.
Borges ÁH; Hoy J; Florence E; Sedlacek D; Stellbrink HJ; Uzdaviniene V; Tomazic J; Gargalianos-Kakolyris P; Schmid P; Orkin C; Pedersen C; Leen C; Pradier C; Mulcahy F; Ridolfo AL; Staub T; Maltez F; Weber R; Flamholc L; Kyselyova G; Lundgren JD; Mocroft A;
Clin Infect Dis; 2017 May; 64(10):1413-1421. PubMed ID: 28329090
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 infections post-vaccination by HIV status in the United States.
Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon K; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg M; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
medRxiv; 2021 Dec; ():. PubMed ID: 34909791
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dementia risk after age 50 between individuals with and without HIV infection.
Lam JO; Hou CE; Hojilla JC; Anderson AN; Gilsanz P; Alexeeff SE; Levine-Hall T; Hood N; Lee C; Satre DD; Silverberg MJ
AIDS; 2021 Apr; 35(5):821-828. PubMed ID: 33394681
[TBL] [Abstract][Full Text] [Related]
12. Brief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era.
Ruderman SA; Crane HM; Nance RM; Whitney BM; Harding BN; Mayer KH; Moore RD; Eron JJ; Geng E; Mathews WC; Rodriguez B; Willig AL; Burkholder GA; Lindström S; Wood BR; Collier AC; Vannappagari V; Henegar C; Van Wyk J; Curtis L; Saag MS; Kitahata MM; Delaney JAC
J Acquir Immune Defic Syndr; 2021 Mar; 86(3):339-343. PubMed ID: 33148997
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with fractures in HIV-infected persons: which factors matter?
Gedmintas L; Wright EA; Dong Y; Lehmann E; Katz JN; Solomon DH; Losina E
Osteoporos Int; 2017 Jan; 28(1):239-244. PubMed ID: 27421978
[TBL] [Abstract][Full Text] [Related]
14. Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific.
Tanuma J; Jiamsakul A; Makane A; Avihingsanon A; Ng OT; Kiertiburanakul S; Chaiwarith R; Kumarasamy N; Nguyen KV; Pham TT; Lee MP; Ditangco R; Merati TP; Choi JY; Wong WW; Kamarulzaman A; Yunihastuti E; Sim BL; Ratanasuwan W; Kantipong P; Zhang F; Mustafa M; Saphonn V; Pujari S; Sohn AH;
PLoS One; 2016; 11(8):e0161562. PubMed ID: 27560968
[TBL] [Abstract][Full Text] [Related]
15. Tenofovir and bone health.
Grant PM; Cotter AG
Curr Opin HIV AIDS; 2016 May; 11(3):326-32. PubMed ID: 26859637
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Events in an Inner-City HIV Clinic and Relationship to Abacavir Versus Tenofovir Disoproxil Fumarate-Containing Antiretroviral Regimens.
Varriano B; Crouzat F; Sandler I; Smith G; Kovacs C; Gupta M; Brunetta J; Fletcher D; Knox D; Merkley B; Chang B; Tilley D; Acsai M; Loutfy M
AIDS Res Hum Retroviruses; 2021 Jan; 37(1):44-53. PubMed ID: 33019803
[TBL] [Abstract][Full Text] [Related]
17. Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.
Suzuki S; Nishijima T; Kawasaki Y; Kurosawa T; Mutoh Y; Kikuchi Y; Gatanaga H; Oka S
AIDS Patient Care STDS; 2017 Mar; 31(3):105-112. PubMed ID: 28282247
[TBL] [Abstract][Full Text] [Related]
18. The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study.
Alvarez E; Campbell L; Tinago W; Garcia-Leon A; Walsh I; Brady JJ; Burling K; Noe S; Neuville MF; Jouret F; Jamshidian F; Graham H; Rhee M; Mallon PW; Post FA
Antivir Ther; 2022 Aug; 27(4):13596535221094898. PubMed ID: 36000318
[TBL] [Abstract][Full Text] [Related]
19. Proteinuria Is Associated With Increased Risk of Fragility Fracture in Men With or at Risk of HIV Infection.
Gonciulea A; Wang R; Althoff KN; Estrella MM; Sellmeyer DE; Palella FJ; Lake JE; Kingsley LA; Brown TT
J Acquir Immune Defic Syndr; 2019 Jul; 81(3):e85-e91. PubMed ID: 30939529
[TBL] [Abstract][Full Text] [Related]
20. Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case-Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4).
Costagliola D; Potard V; Lang S; Abgrall S; Duvivier C; Fischer H; Joly V; Lacombe JM; Valantin MA; Mary-Krause M; Rozenberg S
J Acquir Immune Defic Syndr; 2019 Feb; 80(2):214-223. PubMed ID: 30422911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
